Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Patent CN112457235A reveals a scalable, high-yield route for 7-methylindole, eliminating cryogenic needs and offering significant cost reduction in API manufacturing.
Patent CN104892459A details a concise Riociguat intermediate route. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN111484524A details a novel C15 intermediate synthesis for vitamin A acetate, offering high yield, safety, and cost reduction for pharmaceutical manufacturers.
Novel catalytic method for Salidroside production. High yield, cost-effective, scalable supply chain solution for pharmaceutical and cosmetic industries.
Patent CN114621228B reveals high-yield synthesis reducing waste. Offers cost reduction in antiviral drug manufacturing and reliable supply chain solutions.
Deep dive into enantioselective sulfoximine synthesis via iron-catalyzed oxidation. Offers cost reduction in agrochemical intermediate manufacturing and scalable supply solutions.
Patent CN111560005A details green synthesis of 2-thiopheneacetyl chloride offering high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN103360425A details a novel synthesis of Tenofovir Disoproxil Fumarate, offering higher purity and yield while eliminating toxic azeotropic agents for cost-effective manufacturing.
Novel pyrrole-based route for Aldisin synthesis offering higher yield and safer solvents. Ideal for reliable API intermediate supply chains and cost reduction.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN111285760B details a novel Suzuki coupling route for Bempedoic acid, eliminating column chromatography to ensure high purity and scalable API intermediate manufacturing.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.
Novel synthesis of monoamine inhibitor intermediate via selenylation. High purity, scalable route for pharmaceutical supply chains.
Novel hydrogenation-cyclization route offers high yield and mild conditions for scalable production of protected diazaspiro compounds.
Patent CN113185431B reveals a chromium-free route for Menadione Sodium Bisulfite using air oxidation, offering significant cost reduction and supply chain stability for feed additive manufacturers.
Patent CN1189458C details a chiral pool synthesis of key Substance P antagonists. Discover cost-effective manufacturing and supply chain advantages.
Patent CN1266145C reveals a novel ester-mediated synthesis of Δ9-THC, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing without heavy metal residues.
Patent CN107880063B details high-yield dauricine synthesis. This method offers significant supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Advanced preparation method for olmesartan medoxomil intermediates using novel tetrazole protection. Reduces impurities and simplifies purification for API manufacturing.